Prognostic Stratification of the IMDC Intermediate Risk Group After Treatment With First-line Molecular-targeted Therapy for Metastatic Renal Cell Carcinoma
暂无分享,去创建一个
H. Miyake | R. Ando | T. Yasui | M. Sumitomo | K. Takahara | R. Shiroki | Toshiki Ito | K. Kanao